Physician profile
Hunter Hsu
NPI 1285052753
$6,925.92
in general payments reported to CMS, 2019-2025
21 companies · $1,705 in 2025
The $1,705 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,211 · 2020: $286 · 2021: $1,091 · 2022: $30.69 · 2023: $403 · 2024: $201 · 2025: $1,705.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,430 · Travel and Lodging: $878.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,430.06 |
| Travel and Lodging | $877.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,728.98 | 2019-2025 | Mako |
| Smith+Nephew, INC. | $1,035.23 | 2019-2023 | Synergy, Tandem, Redapt |
| Microport Orthopedics INC | $261.63 | 2019 | |
| Zimmer Biomet Holdings, INC. | $205.85 | 2025 | Persona |
| Kci USA, INC. | $112.57 | 2019 | |
| Depuy Synthes Sales INC. | $96.72 | 2020-2024 | Orthovisc, Monovisc |
| Medtronic USA, INC. | $89.09 | 2020 | |
| Ferring Pharmaceuticals INC. | $88.87 | 2021-2025 | Euflexxa |
| Biocomposites INC | $35.71 | 2019 | |
| Bioventus LLC | $30.90 | 2024-2025 | Durolane |
| Pacira Therapeutics, INC. | $30.55 | 2020 | |
| Acera Surgical, INC. | $28.33 | 2025 | Restrata Wound Matrix |
| Innovation Technologies INC | $27.82 | 2025 | Irrisept |
| Vertex Pharmaceuticals Incorporated | $27.15 | 2025 | |
| Medical Device Business Services, INC. | $20.75 | 2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $20.45 | 2024 | Evenity, Prolia |
| Becton, Dickinson and Company | $20.25 | 2023 | |
| Ethicon US, LLC | $18.55 | 2024 | Evarrest, Surgiflo Hemostatic Matrix, Surgicel Nu-Knit |
| Boston Scientific Corporation | $17.15 | 2022 | |
| Abbvie INC. | $16.72 | 2024 | |
| Bsn Medical INC | $12.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hunter Hsu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.